Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer
暂无分享,去创建一个
M. Nishino | L. Sholl | M. Awad | R. Umeton | S. Dahlberg | S. Kravets | B. Ricciuti | S. Subegdjo | B. Johnson | Adem Albayrak